EN DE
STOCK COMPARISON

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B vs Eli Lilly &: Fair Value & Quality

Both stocks run through our valuation models. Here is how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) and Eli Lilly & (LLY) compare, as of Aug 12, 2026.

As of Aug 12, 2026, Fair Value Calculator sees Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B as the less overvalued of the two: Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B trades at ¥0.45 versus a fair value of ¥0.32 (-28%), while Eli Lilly & trades at $1,215 versus $397 (-67%).
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
900904.SHG · CNY · Health Care
-28%
upside to fair value
overvalued
Price¥0.45
Fair Value¥0.32
Quality59/100
Eli Lilly &
LLY · USD · Health Care
-67%
upside to fair value
overvalued
Price$1,215
Fair Value$397
Quality69/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd BEli Lilly &
Valuation
42.7×P/E (TTM)42.2×
—P/S (TTM)14.67×
—P/B39.94×
—EV/EBITDA30.2×
—PEG1.54×
—Dividend yield0.5%
—Dividend per share$6.23
Profitability
2%Net margin35%
5%Operating margin49%
1%Return on equity107%
1%Return on assets21%
Growth
-12%Revenue growth (YoY)56%
-6.5%Avg. growth/yr (3Y)31.7%
1.4%Avg. growth/yr (5Y)21.6%
Balance & size
0.04×Debt / equity1.54×
$238MMarket cap$1.1T
mixedGrowth qualitymixed

Eli Lilly & leads: 1 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Bof which business quality 59 · market factors 46 Eli Lilly &of which business quality 65 · market factors 84
ProfitabilityMargins and returns on capital today
31
85
Quality GrowthAre margins and returns improving?
31
86
CashflowEarnings quality: real cash, not paper profit
57
51
Fin. StrengthBalance sheet, leverage, solvency risk
69
53
InvestmentDisciplined investing over empire-building
100
15
Low VolatilityCalm price path (market factor)
98
77
MomentumPrice trend over the last 3–12 months (market factor)
27
81
52W MomentumDistance to the 52-week high (market factor)
18
97
Net IssuanceBuybacks instead of dilution
82
93

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

DCF Models¥2.62
Earnings-Based¥1.37
Multiples¥2.61
Asset-Based¥2.91
Growth DCF¥2.85
Economic Profit¥2.29
Growth Earnings¥1.19

0 of 22 models see the stock below the current price.

Eli Lilly &

DCF Models$334
Earnings-Based$239
Dividend Discount$115
Multiples$358
Asset-Based$19.94
Growth DCF$187
Economic Profit$347
Growth Earnings$375

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
Bear ¥0.30Fair Value ¥0.32Bull ¥0.32
¥0.45 = current price (white tick)
Eli Lilly &
Bear $222Fair Value $397Bull $582
$1,215 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B · Health Care

Quality score59 · above median
Fair value upside-28% · above median

Eli Lilly & · Health Care

Quality score69 · Top 25%
Fair value upside-67% · bottom 25%

Bottom line

As of Aug 12, 2026, Fair Value Calculator sees Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B as the less overvalued of the two: Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B trades at ¥0.45 versus a fair value of ¥0.32 (-28%), while Eli Lilly & trades at $1,215 versus $397 (-67%).

Eli Lilly & has the higher quality score (69/100).

See the full analysis →
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B · Eli Lilly &

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Eli Lilly &

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.